| |
|
|
|
GenMark Diagnostics- Inc.  
|
|
7.07 -0.04 (-0.01%) |
06-22 16:00 |
|
Open: |
7.13 |
Pre close: |
7.11 |
Target:
|
8.67
|
|
High: |
7.16 |
Low: |
7.04 |
Resistance:
|
7.43
7.87
|
|
Volume: |
181,184 |
Market Cap: |
392M |
Support:
|
6.71
5.58
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.18
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
7.23  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
5.92 |
Stochastic Oscillator |
%K(14,3):
|
27.82 |
|
MA(250): |
7.10 |
%D(3): |
32.18 |
|
Average Volume(K) |
3-Month: |
28399
|
52-Week |
High:
|
12.68 |
|
10-Days: |
29364 |
Low: |
3.63 |
|
RSI |
RSI(14):
|
49.81 |
Change(%): |
-43.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.120 |
Return on Equity (ttm) |
-126.5 |
Shares Out. (M) |
55.41 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-64.1 |
Shares Float (M) |
52.27 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.20 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
64.7 |
% Held by Institutions |
95.70 |
|
Forward EPS |
-0.630 |
Gross Profit (p.s.) |
0.164 |
Shares Short (K) |
6554 |
|
Book Value (p.s.) |
6.480 |
EBITDA (p.s.) |
-0.523 |
P/E |
-6.31 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.09 |
|
Profit Margin |
-97.29 |
Operating Cash Flow
(M) |
-43.91 |
P/S |
343639232.00 |
|
Operating Margin |
-93.60 |
Levered Free Cash Flow
(M) |
-20.53 |
P/CF |
-8.92 |
|
|
|
|
|
|
